Federico Cappuzzo, M., Zanete Zvirbule, M., Ernesto Korbenfeld, M., Jaroslaw Kolb-Sielecki, M., Dolores Isla, M., Aleksandra Szczesna, M., . . . Margarita Majem, M. Primary Results from IMscin002: A Study to Evaluate Patient Preferences and Perceptions of Health Care Professionals for Atezolizumab Subcutaneous Versus Intravenous for the Treatment of NSCLC. Elsevier.
Chicago Style (17th ed.) CitationFederico Cappuzzo, MD, et al. Primary Results from IMscin002: A Study to Evaluate Patient Preferences and Perceptions of Health Care Professionals for Atezolizumab Subcutaneous Versus Intravenous for the Treatment of NSCLC. Elsevier.
MLA (9th ed.) CitationFederico Cappuzzo, MD, et al. Primary Results from IMscin002: A Study to Evaluate Patient Preferences and Perceptions of Health Care Professionals for Atezolizumab Subcutaneous Versus Intravenous for the Treatment of NSCLC. Elsevier.